View in EDS HTML Full Text PDF Full Text

Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

Saved in:
Bibliographic Details
Title: Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.
Authors: Ali HM; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Mazzoni S; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Goel U; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA., Khouri J; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Anwer F; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Williams LS; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Basali D; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Samaras CJ; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Faiman BM; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Van Heeckeren W; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Hamilton K; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Rudoni J; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Rice M; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Kissam J; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Scott C; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Mathur S; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., McDonald A; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Roy T; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Bevacqua J; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Pasquini MC; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Valent J; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Raza S; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. razas@ccf.org.
Source: Blood cancer journal [Blood Cancer J] 2026 Apr 29; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 29.
Publication Type: Letter
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42056076
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ali+HM%22">Ali HM</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mazzoni+S%22">Mazzoni S</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Goel+U%22">Goel U</searchLink>; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Khouri+J%22">Khouri J</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Anwer+F%22">Anwer F</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Williams+LS%22">Williams LS</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Basali+D%22">Basali D</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Samaras+CJ%22">Samaras CJ</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Faiman+BM%22">Faiman BM</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Van+Heeckeren+W%22">Van Heeckeren W</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+K%22">Hamilton K</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rudoni+J%22">Rudoni J</searchLink>; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rice+M%22">Rice M</searchLink>; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kissam+J%22">Kissam J</searchLink>; Department of Pharmacy, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Scott+C%22">Scott C</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mathur+S%22">Mathur S</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22McDonald+A%22">McDonald A</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Roy+T%22">Roy T</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Bevacqua+J%22">Bevacqua J</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pasquini+MC%22">Pasquini MC</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Valent+J%22">Valent J</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Raza+S%22">Raza S</searchLink>; Department of Hematology and Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. razas@ccf.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2026 Apr 29; Vol. 16 (1). <i>Date of Electronic Publication: </i>2026 Apr 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42056076
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-026-01512-z
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ali HM
      – PersonEntity:
          Name:
            NameFull: Mazzoni S
      – PersonEntity:
          Name:
            NameFull: Goel U
      – PersonEntity:
          Name:
            NameFull: Khouri J
      – PersonEntity:
          Name:
            NameFull: Anwer F
      – PersonEntity:
          Name:
            NameFull: Williams LS
      – PersonEntity:
          Name:
            NameFull: Basali D
      – PersonEntity:
          Name:
            NameFull: Samaras CJ
      – PersonEntity:
          Name:
            NameFull: Faiman BM
      – PersonEntity:
          Name:
            NameFull: Van Heeckeren W
      – PersonEntity:
          Name:
            NameFull: Hamilton K
      – PersonEntity:
          Name:
            NameFull: Rudoni J
      – PersonEntity:
          Name:
            NameFull: Rice M
      – PersonEntity:
          Name:
            NameFull: Kissam J
      – PersonEntity:
          Name:
            NameFull: Scott C
      – PersonEntity:
          Name:
            NameFull: Mathur S
      – PersonEntity:
          Name:
            NameFull: McDonald A
      – PersonEntity:
          Name:
            NameFull: Roy T
      – PersonEntity:
          Name:
            NameFull: Bevacqua J
      – PersonEntity:
          Name:
            NameFull: Pasquini MC
      – PersonEntity:
          Name:
            NameFull: Valent J
      – PersonEntity:
          Name:
            NameFull: Raza S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 04
              Text: 2026 Apr 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1